August J. Troendle has bought MEDP on 10 days since Jul 2022
President and CEO at Medpace Holdings, Inc.
SEC CIK 0001622058 · Filings on SEC.gov ↗
August J. Troendle's record
3 months after each buy, from the first price a copier could get.
10 buys since 2022 with 3 months of prices.
Every filing
127 filings since Aug 2018, newest first
Medpace Holdings, Inc.
President and CEO
Medpace Holdings, Inc.
President and CEO
Medpace Holdings, Inc.
President and CEO
Medpace Holdings, Inc.
President and CEO
Medpace Holdings, Inc.
President and CEO
Medpace Holdings, Inc.
President and CEO
Medpace Holdings, Inc.
President and CEO
Medpace Holdings, Inc.
President and CEO
Medpace Holdings, Inc.
President and CEO
Medpace Holdings, Inc.
President and CEO
Medpace Holdings, Inc.
President and CEO
Medpace Holdings, Inc.
President and CEO
Medpace Holdings, Inc.
President and CEO
Medpace Holdings, Inc.
CEO and 10% owner
Medpace Holdings, Inc.
CEO and 10% owner
Medpace Holdings, Inc.
CEO and 10% owner
Medpace Holdings, Inc.
CEO and 10% owner
Medpace Holdings, Inc.
CEO and 10% owner
Medpace Holdings, Inc.
CEO and 10% owner
Medpace Holdings, Inc.
CEO and 10% owner
Medpace Holdings, Inc.
CEO and 10% owner
Medpace Holdings, Inc.
CEO and 10% owner
Medpace Holdings, Inc.
CEO and 10% owner
Medpace Holdings, Inc.
CEO and 10% owner
Medpace Holdings, Inc.
CEO and 10% owner
Medpace Holdings, Inc.
CEO and 10% owner
Medpace Holdings, Inc.
CEO and 10% owner
Medpace Holdings, Inc.
CEO and 10% owner
Medpace Holdings, Inc.
CEO and 10% owner
Medpace Holdings, Inc.
CEO and 10% owner
Medpace Holdings, Inc.
CEO and 10% owner
Medpace Holdings, Inc.
CEO and 10% owner
Medpace Holdings, Inc.
CEO and 10% owner
Medpace Holdings, Inc.
CEO and 10% owner
Medpace Holdings, Inc.
CEO and 10% owner
Medpace Holdings, Inc.
CEO and 10% owner
Medpace Holdings, Inc.
CEO and 10% owner
Medpace Holdings, Inc.
CEO and 10% owner
Medpace Holdings, Inc.
CEO and 10% owner
Medpace Holdings, Inc.
CEO and 10% owner
Medpace Holdings, Inc.
CEO and 10% owner
Medpace Holdings, Inc.
CEO and 10% owner
Medpace Holdings, Inc.
CEO and 10% owner
Medpace Holdings, Inc.
CEO and 10% owner
Medpace Holdings, Inc.
CEO and 10% owner
Medpace Holdings, Inc.
CEO and 10% owner
Medpace Holdings, Inc.
CEO and 10% owner
Medpace Holdings, Inc.
CEO and 10% owner
Medpace Holdings, Inc.
CEO and 10% owner
Medpace Holdings, Inc.
CEO and 10% owner
About August J. Troendle
August J. Troendle, MD, is the Founder, Chief Executive Officer, and Chairman of the Board of Directors of Medpace Holdings, Inc. (MEDP), a global full-service clinical research organization (CRO) headquartered in Cincinnati, Ohio.( He established the company in July 1992, initially as Medical Research Services, after gaining expertise in clinical development at Sandoz (now Novartis) from 1987 to 1992, where he managed lipid-altering agents, and as a Medical Review Officer at the FDA's Division of Metabolic and Endocrine Drug Products from 1986 to 1987.(
Dr. Troendle, aged 69, holds a Medical Degree from the University of Maryland School of Medicine and a Master of Business Administration from Boston University.( His career highlights include directing clinical research in cardio-metabolic, oncology, CNS, and other therapeutic areas, and serving on boards of companies such as Coherus BioSciences (2012-2018), Xenon Pharmaceuticals (2007-2008), LIB Therapeutics (since 2015), CinCor Pharma (2018-2021), and CinRx Pharma (since 2015).( As a corporate insider and CEO owning approximately 10% of MEDP, he has a proven track record leading the firm since its public listing in 2016.(
Written by Perplexity from public sources.
Filings come from SEC EDGAR. Not investment advice.